1.2 million US dollar award honors pioneering work in cryo-electron tomography
Wolfgang Baumeister receives prestigious Shaw Prize
Advertisement
Wolfgang Baumeister, Director Emeritus at the Max Planck Institute of Biochemistry in Martinsried near Munich, is being awarded the prestigious 2025 Shaw Prize in Life Sciences and Medicine. The award recognizes his pioneering development and use of cryo-electron tomography (cryo-ET), an imaging technique that enables three-dimensional visualization of biological samples. This revolutionary method allows proteins, macromolecular complexes, and cellular compartments to be viewed in their natural cellular settings. The Shaw Prize, endowed with 1.2 million US dollars, will be presented in Hong Kong on October 21.
Human cells contain billions of proteins and other biological molecules that work together to keep cells, and thus organisms, alive. While scientists have long had detailed lists of individual cellular components and their isolated structures, they lacked an understanding of how these components interact in the cell. Baumeister's development of cryo-ET closes this gap, enabling the observation of biological processes in their original, densely packed cellular environment for the first time.
In cryo-ET, cells are flash-frozen to prevent ice crystal formation. The cells' structure remains in a glass-like state. A transmission electron microscope takes two-dimensional images from different angles, similar to computer tomography in medical diagnostics. Researchers can then use a computer to assemble these images into a three-dimensional model, revealing the cellular structure at the molecular level in its natural environment. Over the past few decades, Baumeister and his team have refined the method by combining many innovations.
The Shaw Prize now recognizes Wolfgang Baumeister's extraordinary contributions to structural biology. According to the Shaw Foundation's press release, “Baumeister has developed and applied methods to reveal the inner workings of cells at an unprecedented, near-atomic level. The power of this technology is transforming our understanding of normal life processes and how they go awry in disease."
About the awardee: Wolfgang Baumeister studied biology, chemistry, and physics at the universities of Münster and Bonn, receiving his doctorate in biophysics in 1973 from Heinrich Heine University Düsseldorf in the lab of Helmut Ruska. His scientific career took him to positions as a research assistant at HHU (1973–1980) and as a Heisenberg Fellow at the Cavendish Laboratory at the University of Cambridge (1981–1982) before joining the Max Planck Institute of Biochemistry, where he worked from 1983 to 2021, first as group leader of Molecular Structural Biology and later as director. Since 1987, he is an extraordinary professor with teaching privileges at the Faculty of Chemistry at the Technical University of Munich. Baumeister also holds an honorary professorship at the Faculty of Physics at the Technical University of Munich since 2000. And since 2023, he has been a distinguished adjunct professor at ShanghaiTech University in China. Baumeister is a member of the German Academy of Sciences Leopoldina and the US National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. He has received numerous awards for his research, including the Warburg Medal (1998), the Louis-Jeantet Prize for Medicine (2003), the Harvey Prize for Science and Technology (2005), the Alexander Hollaender Award in Biophysics (2022) and the Rosenstiel Award in Basic Medical Sciences (2023).
About the Shaw Prize: This year marks the 22nd time the Shaw Prize is being awarded. Alongside the Japan Prize, it is considered one of the most important scientific awards in Asia. Previus winners from the Max Planck Society include Simon D. M. White, who received the award in astronomy in 2017, and Reinhard Genzel in 2008. In mathematics, Gerd Faltings was honored in 2015; in the life sciences, F. Ulrich Hartl won the prize in 2012 and Patrick Cramer received it in 2023.
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer
Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor
Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors
New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform - A revolution in drug discovery thanks to a new chat assistant?
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research
New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments
CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma - First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBM
First-of-its-kind vaccine expands malaria protection for pregnant women - Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years
